CHAPTER 2. CLASSIFICATION OF DRUGS
IC 35-48-2
Chapter 2. Classification of Drugs
IC 35-48-2-1
Considerations of board determinations on substances; exclusionof a narcotic substance from schedule
Sec. 1. (a) The board shall administer this article and mayrecommend to the general assembly the addition, deletion, orrescheduling of all substances listed in the schedules in sections 4,6, 8, 10, and 12 of this chapter by submitting in an electronic formatunder IC 5-14-6 a report of such recommendations to the legislativecouncil. In making a determination regarding a substance, the boardshall consider the following:
(1) The actual or relative potential for abuse.
(2) The scientific evidence of its pharmacological effect, ifknown.
(3) The state of current scientific knowledge regarding thesubstance.
(4) The history and current pattern of abuse.
(5) The scope, duration, and significance of abuse.
(6) The risk to public health.
(7) The potential of the substance to produce psychic orphysiological dependence liability.
(8) Whether the substance is an immediate precursor of asubstance already controlled under this article.
(b) After considering the factors enumerated in subsection (a), theboard shall make findings and recommendations concerning thecontrol of the substance if it finds the substance has a potential forabuse.
(c) If the board finds that a substance is an immediate precursor,substances which are precursors of the controlled precursor shall notbe subject to control solely because they are precursors of thecontrolled precursor.
(d) If any substance is designated or rescheduled to a morerestrictive schedule as a controlled substance under federal law andnotice is given to the board, the board shall recommend similarcontrol of the substance under this article in the board's report to thegeneral assembly, unless the board objects to inclusion orrescheduling. In that case, the board shall publish the reasons forobjection and afford all interested parties an opportunity to be heard.At the conclusion of the hearing, the board shall publish its findings.
(e) If a substance is rescheduled to a less restrictive schedule ordeleted as a controlled substance under federal law, the substance isrescheduled or deleted under this article. If the board objects toinclusion, rescheduling, or deletion of the substance, the board shallnotify the chairman of the legislative council not more than thirty(30) days after the federal law is changed and the substance may notbe rescheduled or deleted until the conclusion of the next completesession of the general assembly. The notice from the board to thechairman of the legislative council must be published. (f) The board shall conduct hearings regarding revocations,suspensions, and restrictions of registrations as provided inIC 35-48-3-4. All hearings shall be conducted in accordance withIC 4-21.5-3.
(g) Authority to control under this section does not extend todistilled spirits, wine, or malt beverages, as those terms are definedor used in IC 7.1, or to tobacco.
(h) The board shall exclude any nonnarcotic substance from aschedule if that substance may, under the Federal Food, Drug, andCosmetic Act or state law, be sold over the counter without aprescription.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977,P.L.344, SEC.1; P.L.137-1985, SEC.17; P.L.200-1987, SEC.4;P.L.188-1989, SEC.4; P.L.33-1993, SEC.73; P.L.163-1994, SEC.2;P.L.177-1997, SEC.8; P.L.14-2000, SEC.77; P.L.107-2002, SEC.31;P.L.28-2004, SEC.178; P.L.84-2010, SEC.92.
IC 35-48-2-1.1
Repealed
(Repealed by P.L.2-1995, SEC.140.)
IC 35-48-2-1.5
Repealed
(Repealed by P.L.84-2010, SEC.102.)
IC 35-48-2-2
Nomenclature
Sec. 2. Nomenclature. The controlled substances listed in theschedules in sections 4, 6, 8, 10 and 12 of this chapter are includedby whatever official, common, usual, chemical, or trade namedesignated. The number placed in brackets after each substance is itsfederal Drug Enforcement Administration Controlled SubstancesCode Number which is to be used for identification purposes oncertain certificates of registration.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1979,P.L.303, SEC.2.
IC 35-48-2-3
Schedule I tests
Sec. 3. (a) The board shall recommend placement of a substancein schedule I under this chapter if it finds that the substance:
(1) has high potential for abuse; and
(2) has no accepted medical use in treatment in the UnitedStates or lacks accepted safety for use in treatment undermedical supervision.
(b) The board may recommend placement of a substance inschedule I under this chapter if it finds that the substance is classifiedas a controlled substance in schedule I under federal law.
As added by Acts 1976, P.L.148, SEC.7. Amended by P.L.200-1987,SEC.6.
IC 35-48-2-4
Schedule I
Sec. 4. (a) The controlled substances listed in this section areincluded in schedule I.
(b) Opiates. Any of the following opiates, including their isomers,esters, ethers, salts, and salts of isomers, esters, and ethers, unlessspecifically excepted by rule of the board or unless listed in anotherschedule, whenever the existence of these isomers, esters, ethers, andsalts is possible within the specific chemical designation:
Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) (9815)
Acetylmethadol (9601)
Allylprodine (9602)
Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
Alphacetylmethadol (9603)
Alphameprodine (9604)
Alphamethadol (9605)
Alphamethylfentanyl (9814)
Benzethidine (9606)
Beta-hydroxy-3-methylfentanyl (9831). Other name:N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
]-N-phenylpropanamide.
Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
Betacetylmethadol (9607)
Betameprodine (9608)
Betamethadol (9609)
Betaprodine (9611)
Clonitazene (9612)
Dextromoramide (9613)
Diampromide (9615)
Diethylthiambutene (9616)
Difenoxin (9168)
Dimenoxadol (9617)
Dimepheptanol (9618)
Dimethylthiambutene (9619)
Dioxaphetyl butyrate (9621)
Dipipanone (9622)
Ethylmethylthiambutene (9623)
Etonitazene (9624)
Etoxeridine (9625)
Furethidine (9626)
Hydroxypethidine (9627)
Ketobemidone (9628)
Levomoramide (9629)
Levophenacylmorphan (9631)
3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
piperidyl]-N-phenyl-propanimide](9813)
3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
piperidinyl]-N-phenylpropanamide) (9833)
MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
Morpheridine (9632)
N-[1-benzyl-4-piperidyl]-N-phenylpropanamide(benzylfentanyl), including any isomers, salts, or salts ofisomers (9818)
N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide(thenylfentanyl), including any isomers, salts, or salts ofisomers (9834)
Noracymethadol (9633)
Norlevorphanol (9634)
Normethadone (9635)
Norpipanone (9636)
Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
Phenadoxone (9637)
Phenampromide (9638)
Phenomorphan (9647)
Phenoperidine (9641)
PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
Piritramide (9642)
Proheptazine (9643)
Properidine (9644)
Propiram (9649)
Racemoramide (9645)
Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-piperidinyl]-propanamide) (9835)
Tilidine (9750)
Trimeperidine (9646)
(c) Opium derivatives. Any of the following opium derivatives,their salts, isomers, and salts of isomers, unless specifically exceptedby rule of the board or unless listed in another schedule, wheneverthe existence of these salts, isomers, and salts of isomers is possiblewithin the specific chemical designation:
Acetorphine (9319)
Acetyldihydrocodeine (9051)
Benzylmorphine (9052)
Codeine methylbromide (9070)
Codeine-N-Oxide (9053)
Cyprenorphine (9054)
Desomorphine (9055)
Dihydromorphine (9145)
Drotebanol (9335)
Etorphine (except hydrochloride salt) (9056)
Heroin (9200)
Hydromorphinol (9301)
Methyldesorphine (9302)
Methyldihydromorphine (9304)
Morphine methylbromide (9305)
Morphine methylsulfonate (9306) Morphine-N-Oxide (9307)
Myrophine (9308)
Nicocodeine (9309)
Nicomorphine (9312)
Normorphine (9313)
Pholcodine (9314)
Thebacon (9315)
(d) Hallucinogenic substances. Any material, compound, mixture,or preparation which contains any quantity of the followinghallucinogenic, psychedelic, or psychogenic substances, their salts,isomers, and salts of isomers, unless specifically excepted by rule ofthe board or unless listed in another schedule, whenever theexistence of these salts, isomers, and salts of isomers is possiblewithin the specific chemical designation:
(1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:TCPy.
(2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some tradeor other names: 4-Bromo-2,5-Dimethoxy-a-methylphenethylamine; 4-Bromo-2, 5-DMA.
(3) 4-Bromo-2, 5-dimethoxphenethylamine (7392). Some tradeor other names:
2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;alpha-desmethyl DOB; 2C-B, Nexus.
(4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:DOET.
(5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).Other name: 2C-T-7.
(6) 2, 5-Dimethoxyamphetamine (7396). Some trade or othernames: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
(7) 4-Methoxyamphetamine (7411). Some trade or other names:4-Methoxy-a-methylphenethylamine;Paramethoxyamphetamine; PMA.
(8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). OtherName: MMDA.
(9) 5-Methoxy-N, N-diisopropyltryptamine, including anyisomers, salts, or salts of isomers (7439). Other name:5-MeO-DIPT.
(10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some tradeand other names: 4-methyl-2,5-dimethoxy-a-methylphenethylamine; DOM; and STP.
(11) 3, 4-methylenedioxy amphetamine (7400). Other name:MDA.
(12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Othernames: N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-ethyl MDA; MDE; and MDEA.
(13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
(14) 3, 4, 5-trimethoxy amphetamine (7390). Other name:TMA.
(15) Alpha-ethyltryptamine (7249). Some trade and othernames: Etryptamine; Monase;
[alpha]-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole;[alpha]-ET; and AET.
(16) Alpha-methyltryptamine (7432). Other name: AMT.
(17) Bufotenine (7433). Some trade and other names:3-(B-Dimethylaminoethyl)-5-hydroxyindole;3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;5-hydroxy-N, N-dimethyltryptamine; mappine.
(18) Diethyltryptamine (7434). Some trade or other names: N,N-Diethyltryptamine; DET.
(19) Dimethyltrytamine (7435). Some trade or other names:DMT.
(20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6,6b, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,9-methano-5H-pyrido (1', 2': 1, 2, azepino 4, 5-b) indole;tabernanthe iboga.
(21) Lysergic acid diethylamide (7315). Other name: LSD.
(22) Marijuana (7360).
(23) Mescaline (7381).
(24) Parahexyl (7374). Some trade or other names:3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
(25) Peyote (7415), including:
(A) all parts of the plant that are classified botanically aslophophora williamsii lemaire, whether growing or not;
(B) the seeds thereof;
(C) any extract from any part of the plant; and
(D) every compound, manufacture, salt, derivative, mixture,or preparation of the plant, its seeds, or extracts.
(26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
(27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Othernames: N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine; and N-hydroxy MDA.
(28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
(29) Psilocybin (7437).
(30) Psilocyn (7438).
(31) Tetrahydrocannabinols (7370), including syntheticequivalents of the substances contained in the plant, or in theresinous extractives of Cannabis, sp. and synthetic substances,derivatives, and their isomers with similar chemical structureand pharmacological activity such as:
(A) .1 cis or trans tetrahydrocannabinol, and their opticalisomers;
(B) .6 cis or trans tetrahydrocannabinol, and their opticalisomers; and
(C) .3,4 cis or trans tetrahydrocannabinol, and their opticalisomers.
Since nomenclature of these substances is not internationallystandardized, compounds of these structures, regardless ofnumerical designation of atomic positions are covered. Othername: THC. (32) Ethylamine analog of phencyclidine (7455). Some trade orother names: N-Ethyl-1-phenylcyclohexylamine;(1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE.
(33) Pyrrolidine analog of phencyclidine (7458). Some trade orother names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy; PHP.
(34) Thiophene analog of phencyclidine (7470). Some trade orother names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-ThienylAnalog of Phencyclidine; TPCP.
(e) Depressants. Unless specifically excepted in a rule adopted bythe board or unless listed in another schedule, any material,compound, mixture, or preparation which contains any quantity ofthe following substances having a depressant effect on the centralnervous system, including its salts, isomers, and salts of isomerswhenever the existence of such salts, isomers, and salts of isomers ispossible within the specific chemical designation:
Gamma-hydroxybutyric acid (other names include GHB;gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodiumoxybate; sodium oxybutyrate) (2010)
Mecloqualone (2572)
Methaqualone (2565)
(f) Stimulants. Unless specifically excepted or unless listed inanother schedule, any material, compound, mixture, or preparationthat contains any quantity of the following substances having astimulant effect on the central nervous system, including its salts,isomers, and salts of isomers:
([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)
Aminorex (1585). Other names: aminoxaphen;2-amino-5-phenyl-2-oxazoline; or4,5-dihydro-5-phenyl-2-oxazolamine.
Cathinone (1235). Some trade or other names:2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;2-aminopropiophenone; and norephedrone.
Fenethylline (1503)
N-Benzylpiperazine (7493). Other names: BZP; and1-benzylpiperazine.
N-ethylamphetamine (1475)
Methcathinone (1237) Some other trade names:2-Methylamino-1-Phenylpropan-I-one; Ephedrone;Monomethylpropion; UR 1431.
N, N-dimethylamphetamine (1480). Other names: N,N-alpha-trimethyl-benzeneethanamine; and N,N-alpha-trimethylphenethylamine.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1979,P.L.303, SEC.3; Acts 1981, P.L.170, SEC.2; P.L.333-1983, SEC.1;P.L.327-1985, SEC.1; P.L.156-1986, SEC.4; P.L.200-1987, SEC.7;P.L.163-1994, SEC.3; P.L.2-1996, SEC.286; P.L.288-2001, SEC.15;P.L.22-2008, SEC.1.
IC 35-48-2-5
Schedule II tests
Sec. 5. (a) The board shall recommend placement of a substancein schedule II under this chapter if it finds that:
(1) the substance has high potential for abuse;
(2) the substance has currently accepted medical use intreatment in the United States, or currently accepted medicaluse with severe restrictions; and
(3) the abuse of the substance may lead to severe psychologicalor physical dependence.
(b) The board may recommend placement of a substance inschedule II under this chapter if it finds that the substance isclassified as a controlled substance in schedule II under federal law.
As added by Acts 1976, P.L.148, SEC.7. Amended by P.L.200-1987,SEC.8.
IC 35-48-2-6
Schedule II
Sec. 6. (a) The controlled substances listed in this section areincluded in schedule II.
(b) Any of the following substances, except those narcotic drugslisted in other schedules, whether produced directly or indirectly byextraction from substances of vegetable origin, or independently bymeans of chemical synthesis, or by combination of extraction andchemical synthesis:
(1) Opium and opiate, and any salt, compound, derivative, orpreparation of opium or opiate, excluding apomorphine,dextrorphan, nalbuphine, naloxone, naltrexone, and theirrespective salts but including:
(A) raw opium (9600);
(B) opium extracts (9610);
(C) opium fluid extracts (9620);
(D) powdered opium (9639);
(E) granulated opium (9640);
(F) tincture of opium (9630);
(G) codeine (9050);
(H) dihydroetorphine (9334);
(I) ethylmorphine (9190);
(J) etorphine hydrochloride (9059);
(K) hydrocodone (9193);
(L) hydromorphone (9150);
(M) metopon (9260);
(N) morphine (9300);
(O) oxycodone (9143);
(P) oxymorphone (9652); and
(Q) thebaine (9333).
(2) Any salt, compound, isomer, derivative, or preparationthereof which is chemically equivalent or identical with any ofthe substances referred to in subdivision (b)(1) of this section,but not including the isoquinoline alkaloids of opium. (3) Opium poppy and poppy straw.
(4) Cocaine (9041).
(5) Concentrate of poppy straw (the crude extract of poppystraw in either liquid, solid, or powder form which contains thephenanthrene alkaloids of the opium poppy) (9670).
(c) Opiates. Any of the following opiates, including their isomers,esters, ethers, salts, and salts of isomers, esters, and ethers wheneverthe existence of these isomers, esters, ethers, and salts is possiblewithin the specific chemical designation:
Alfentanil (9737)
Alphaprodine (9010)
Anileridine (9020)
Bezitramide (9800)
Bulk dextropropoxyphene (nondosage forms) (9273)
Carfentanil (9743)
Dihydrocodeine (9120)
Diphenoxylate (9170)
Fentanyl (9801)
Isomethadone (9226)
Levo-alphacetylmethadol (9648). Other names:Levo-alpha-acetylmethadol; levomethadyl acetate; and LAAM.
Levomethorphan (9210)
Levorphanol (9220)
Metazocine (9240)
Methadone (9250)
Methadone-Intermediate, 4-cyano-2-dimethyl-amino-4,4-diphenyl butane (9254)
Moramide-Intermediate, 2-methyl-3-morpholino-1,1-diphenylpropane- carboxylic acid (9802)
Pethidine (Meperidine) (9230)
Pethidine-Intermediate- A,4-cyano-1-methyl-4-phenylpiperidine (9232)
Pethidine-Intermediate-B,ethyl-4-phenylpiperidine-4-carboxylate (9233)
Pethidine-Intermediate-C,1-methyl-4-phenylpiperidine-4-carboxylic acid (9234)
Phenazodine (9715)
Piminodine (9730)
Racemethorphan (9732)
Racemorphan (9733)
Remifentanil (9739)
Sufentanil (9740)
(d) Stimulants. Any material compound, mixture, or preparationwhich contains any quantity of the following substances having apotential for abuse associated with a stimulant effect on the centralnervous system:
(1) Amphetamine, its salts, optical isomers, and salts of itsoptical isomers (1100).
(2) Methamphetamine, including its salts, isomers, and salts ofits isomers (1105). (3) Phenmetrazine and its salts (1631).
(4) Methylphenidate (1724).
(e) Depressants. Unless specifically excepted by rule of the boardor unless listed in another schedule, any material, compound,mixture, or preparation which contains any quantity of the followingsubstances having a depressant effect on the central nervous system,including its salts, isomers, and salts of isomers whenever theexistence of such salts, isomers, and salts of isomers is possiblewithin the specific chemical designation:
Amobarbital (2125)
Glutethimide (2550)
Pentobarbital (2270)
Phencyclidine (7471)
Secobarbital (2315)
(f) Immediate precursors. Unless specifically excepted by rule ofthe board or unless listed in another schedule, any material,compound, mixture, or preparation which contains any quantity ofthe following substances:
(1) Immediate precursor to amphetamine andmethamphetamine: Phenylacetone (8501). Some trade or othernames: phenyl-2-propanone; P2P; benzyl methyl ketone; methylbenzyl ketone.
(2) Immediate precursors to phencyclidine (PCP):
(A) 1-phenylcyclohexylamine (7460); or
(B) 1-piperidinocyclohexanecarbonitrile (PCC) (8603).
(g) Hallucinogenic substances:
Nabilone (7379). Other name: (+/-)-trans-3-(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1979,P.L.303, SEC.4; Acts 1981, P.L.170, SEC.3; P.L.333-1983, SEC.2;P.L.77-1984, SEC.13; P.L.327-1985, SEC.2; P.L.156-1986, SEC.5;P.L.329-1987, SEC.1; P.L.31-1998, SEC.9; P.L.22-2008, SEC.2.
IC 35-48-2-7
Schedule III tests
Sec. 7. (a) The board shall recommend placement of a substancein schedule III under this chapter if it finds that:
(1) the substance has a potential for abuse less than thesubstances listed in schedule I and II under this chapter;
(2) the substance has currently accepted medical use intreatment in the United States; and
(3) abuse of the substance may lead to moderate or low physicaldependence or high psychological dependence.
(b) The board may recommend placement of a substance inschedule III under this chapter if it finds that the substance isclassified as a controlled substance in schedule III under federal law.
As added by Acts 1976, P.L.148, SEC.7. Amended by P.L.200-1987,SEC.9.
IC 35-48-2-8
Schedule III
Sec. 8. (a) The controlled substances listed in this section areincluded in schedule III.
(b) Stimulants. Unless specifically excepted or unless listed inanother schedule, any material, compound, mixture, or preparationwhich contains any quantity of the following substances having astimulant effect on the central nervous system, including its salts,isomers (whether optical, position, or geometric), and salts of suchisomers whenever the existence of such salts, isomers, and salts ofisomers is possible within the specific chemical designation:
(1) Those compounds, mixtures, or preparations in dosage unitform containing any stimulant substances listed in schedule IIwhich compounds, mixtures, or preparations were listed onApril 1, 1986, as excepted compounds under 21 CFR 1308.32,and any other drug of the quantitative composition shown inthat list for those drugs or that is the same except that itcontains a lesser quantity of controlled substances (1405).
(2) Benzphetamine (1228).
(3) Chlorphentermine (1645).
(4) Clortermine (1647).
(5) Phendimetrazine (1615).
(c) Depressants. Unless specifically excepted or unless listed inanother schedule, any material, compound, mixture, or preparationwhich contains any quantity of the following substances having adepressant effect on the central nervous system:
(1) Any compound, mixture, or preparation containing:
(A) amobarbital (2126);
(B) secobarbital (2316);
(C) pentobarbital (2271); or
(D) any of their salts;
and one (1) or more other active medicinal ingredients whichare not listed in any schedule.
(2) Any suppository dosage form containing:
(A) amobarbital (2126);
(B) secobarbital (2316);
(C) pentobarbital (2271); or
(D) any of their salts;
and approved by the Food and Drug Administration formarketing only as a suppository.
(3) Any substance which contains any quantity of a derivativeof barbituric acid, or any salt thereof (2100).
(4) Chlorhexadol (2510).
(5) Embutramide (2020).
(6) Lysergic acid (7300).
(7) Lysergic acid amide (7310).
(8) Methyprylon (2575).
(9) Sulfondiethylmethane (2600).
(10) Sulfonethylmethane (2605).
(11) Sulfonmethane (2610). (12) A combination product containing Tiletamine andZolazepam or any salt thereof (Telazol) (7295).
(13) Any drug product containing gamma-hydroxybutyric acid,including its salts, isomers, and salts of isomers, for which anapplication is approved under section 505 of the federal Food,Drug and Cosmetic Act, 21 U.S.C. 301 et seq. (2012).
(d) Nalorphine (a narcotic drug) (9400).
(e) Narcotic Drugs. Unless specifically excepted or unless listedin another schedule, any material, compound, mixture, or preparationcontaining any of the following narcotic drugs, or their saltscalculated as the free anhydrous base or alkaloid, in the followinglimited quantities:
(1) Not more than 1.8 grams of codeine, per 100 milliliters ornot more than 90 milligrams per dosage unit, with an equal orgreater quantity of an isoquinoline alkaloid of opium (9803).
(2) Not more than 1.8 grams of codeine, per 100 milliliters ornot more than 90 milligrams per dosage unit, with one (1) ormore active, nonnarcotic ingredients in recognized therapeuticamounts (9804).
(3) Not more than 300 milligrams of dihydrocodeinone, per 100milliliters or not more than 15 milligrams per dosage unit, witha fourfold or greater quantity of an isoquinoline alkaloid ofopium (9805).
(4) Not more than 300 milligrams of dihydrocodeinone, per 100milliliters or not more than 15 milligrams per dosage unit, withone (1) or more active nonnarcotic ingredients in recognizedtherapeutic amounts (9806).
(5) Not more than 1.8 grams of dihydrocodeine, per 100milliliters or not more than 90 milligrams per dosage unit, withone (1) or more active, nonnarcotic ingredients in recognizedtherapeutic amounts (9807).
(6) Not more than 300 milligrams of ethylmorphine, per 100milliliters or not more than 15 milligrams per dosage unit, withone (1) or more active, nonnarcotic ingredients in recognizedtherapeutic amounts (9808).
(7) Not more than 500 milligrams of opium per 100 millilitersor per 100 grams or not more than 25 milligrams per dosageunit, with one (1) or more active, nonnarcotic ingredients inrecognized therapeutic amounts (9809).
(8) Not more than 50 milligrams of morphine, per 100milliliters or per 100 grams with one (1) or more activenonnarcotic ingredients in recognized therapeutic amounts(9810).
(9) Buprenorphine (9064).
(f) Anabolic steroid (as defined in 21 U.S.C. 802(41)(A) and 21U.S.C. 802(41)(B)).
(g) The board shall except by rule any compound, mixture, orpreparation containing any stimulant or depressant substance listedin subsections (b) through (e) from the application of any part of thisarticle if the compound, mixture, or preparation contains one (1) or
more active medicinal ingredients not having a stimulant ordepressant effect on the central nervous system, and if the admixturesare included therein in combinations, quantity, proportion, orconcentration that vitiate the potential for abuse of the substanceswhich have a stimulant or depressant effect on the central nervoussystem.
(h) Any material, compound, mixture, or preparation whichcontains any quantity of Ketamine (7285).
(i) Hallucinogenic substances:
Dronabinol (synthetic) in sesame oil and encapsulated in a softgelatin capsule in a United States Food and DrugAdministration approved drug product (7369).
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977,P.L.2, SEC.86; Acts 1979, P.L.303, SEC.5; Acts 1981, P.L.170,SEC.4; P.L.333-1983, SEC.3; P.L.200-1987, SEC.10; P.L.48-1991,SEC.76; P.L.1-1994, SEC.171; P.L.31-1998, SEC.10; P.L.288-2001,SEC.16; P.L.22-2008, SEC.3.
IC 35-48-2-9
Schedule IV tests
Sec. 9. (a) The board shall recommend placement of a substancein schedule IV under this chapter if it finds that:
(1) the substance has a low potential for abuse relative tosubstances in schedule III under this chapter;
(2) the substance has currently accepted medical use intreatment in the United States; and
(3) abuse of the substance may lead to limited physicaldependence or psychological dependence relative to thesubstances in schedule III under this chapter.
(b) The board may recommend placement of a substance inschedule IV under this chapter if it finds that the substance isclassified as a controlled substance in schedule IV under federal law.
As added by Acts 1976, P.L.148, SEC.7. Amended by P.L.200-1987,SEC.11.
IC 35-48-2-10
Schedule IV
Sec. 10. (a) The controlled substances listed in this section areincluded in schedule IV.
(b) Narcotic drugs. Unless specifically excepted in a rule adoptedby the board or unless listed in another schedule, any material,compound, mixture, or preparation containing any of the followingnarcotic drugs, or their salts calculated as the free anhydrous base oralkaloid, in the following limited quantities:
(1) Not more than 1 milligram of difenoxin (9618) and not lessthan 25 micrograms of atropine sulfate per dosage unit.
(2) Dextropropoxyphene (alpha- (+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane (9278).
(c) Depressants. Unless specifically excepted in a rule adopted bythe board or unless listed in another schedule, any material,
compound, mixture, or preparation which contains any quantity ofthe following substances, including its salts, isomers, and salts ofisomers whenever the existence of such salts, isomers, and salts ofisomers is possible within the specific chemical designation:
Alprazolam (2882).
Barbital (2145).
Bromazepam (2748).
Camazepam (2749).
Carisoprodol.
Chloral betaine (2460).
Chloral hydrate (2465).
Chlordiazepoxide (2744).
Clobazam (2751).
Clonazepam (2737).
Clorazepate (2768).
Clotiazepam (2752).
Cloxazolam (2753).
Delorazepam (2754).
Diazepam (2765).
Dichloralphenazone (2467).
Estazolam (2756).
Ethchlorvynol (2540).
Ethinamate (2545).
Ethyl loflazepate (2758).
Fludiazepam (2759).
Flunitrazepam (2763).
Flurazepam (2767).
Halazepam (2762).
Haloxazolam (2771).
Ketazolam (2772).
Loprazolam (2773).
Lorazepam (2885).
Lormetazepam (2774).
Mebutamate (2800).
Medazepam (2836).
Meprobamate (2820).
Methohexital (2264).
Methylphenobarbital (mephobarbital) (2250).
Midazolam (2884).
Nimetazepam (2837).
Nitrazepam (2834).
Nordiazepam (2838).
Oxazepam (2835).
Oxazolam (2839).
Paraldehyde (2585).
Petrichloral (2591).
Phenobarbital (2285).
Pinazepam (2883).
Prazepam (2764).
Quazepam (2881). Temazepam (2925).
Tetrazepam (2886).
Triazolam (2887).
Zaleplon (2781).
Zolpidem (Ambien) (2783).
Zopiclone (2784).
(d) Fenfluramine. Any material, compound, mixture, orpreparation which contains any quantity of the following substances,including its salts, isomers (whether optical, position, or geometric),and salts of such isomers, whenever the existence of such salts,isomers, and salts of isomers is possible.
Fenfluramine (1670).
(e) Stimulants. Unless specifically excepted in a rule adopted bythe board or unless listed in another schedule, any material,compound, mixture, or preparation which contains any quantity ofthe following substances having a stimulant effect on the centralnervous system, including its salts, isomers (whether optical,position, or geometric), and salts of such isomers whenever theexistence of such salts, isomers, and salts of isomers is possiblewithin the specific chemical designation:
Cathine ((+)-norpseudoephedrine) (1230).
Diethylpropion (1610).
Fencamfamin (1760).
Fenproporex (1575).
Mazindol (1605).
Mefenorex (1580).
Modafinil (1680).
Phentermine (1640).
Pemoline (including organometallic complexes and chelatesthereof) (1530).
Pipradrol (1750).
Sibutramine (1675).
SPA ((-)-1-dimethylamino-1,2-diphenylethane (1635).
(f) Other substances. Unless specifically excepted or unless listedin another schedule, any material, compound, mixture, or preparationwhich contains any quantity of the following substances including itssalts:
Butorphanol (including its optical isomers) (9720).
Pentazocine (9709).
(g) The board may except by rule any compound, mixture, orpreparation containing any depressant substance listed in subsection(b), (c), (d), (e), or (f) from the application of any part of this articleif the compound, mixture, or preparation contains one (1) or moreactive medicinal ingredients not having a depressant effect on thecentral nervous system, and if the admixtures are included therein incombinations, quantity, proportion, or concentration that vitiate thepotential for abuse of the substances which have a depressant effecton the central nervous system.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977,P.L.344, SEC.2; Acts 1979, P.L.303, SEC.6; Acts 1981, P.L.170,
SEC.5; P.L.333-1983, SEC.4; P.L.77-1984, SEC.14; P.L.200-1987,SEC.12; P.L.288-2001, SEC.17; P.L.8-2004, SEC.3; P.L.22-2008,SEC.4.
IC 35-48-2-11
Schedule V tests
Sec. 11. (a) The board shall recommend placement of a substancein schedule V under this chapter if it finds that:
(1) the substance has low potential for abuse relative to thecontrolled substances listed in schedule IV under this chapter;
(2) the substance has currently accepted medical use intreatment in the United States; and
(3) the substance has limited physical dependence orpsychological dependence liability relative to the controlledsubstances listed in schedule IV under this chapter.
(b) The board may recommend placement of a substance inschedule V under this chapter if it finds that the substance isclassified as a controlled substance in schedule V under federal law.
As added by Acts 1976, P.L.148, SEC.7. Amended by P.L.200-1987,SEC.13.
IC 35-48-2-12
Schedule V
Sec. 12. (a) The controlled substances listed in this section areincluded in schedule V.
(b) Narcotic drugs containing nonnarcotic active medicinalingredients. Any compound, mixture, or preparation containing anyof the following narcotic drugs, or their salts calculated as the freeanhydrous base or alkaloid, in the following quantities, which shallinclude one (1) or more nonnarcotic active medicinal ingredients insufficient proportion to confer upon the compound, mixture, orpreparation, valuable medicinal qualities other than those possessedby the narcotic drug alone:
(1) Not more than 200 milligrams of codeine per 100 millilitersor per 100 grams.
(2) Not more than 100 milligrams of dihydrocodeine per 100milliliters or per 100 grams.
(3) Not more than 100 milligrams of ethylmorphine per 100milliliters or per 100 grams.
(4) Not more than 2.5 milligrams of diphenoxylate and not lessthan 25 micrograms of atropine sulfate per dosage unit.
(5) Not more than 100 milligrams of opium per 100 millilitersor per 100 grams.
(6) Not more than 0.5 milligrams of difenoxin (9168), and notless than 25 micrograms of atropine sulfate per dosage unit.
(c) Pregabalin (2782).
(d) Pyrovalerone (1485).
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1979,P.L.303, SEC.7; Acts 1981, P.L.170, SEC.6; P.L.327-1985, SEC.3;P.L.22-2008, SEC.5.
IC 35-48-2-13
Repealed
(Repealed by Acts 1979, P.L.303, SEC.13.)
IC 35-48-2-14
Reclassification; rules
Sec. 14. (a) The board may adopt rules under IC 4-22-2 toreclassify a controlled substance:
(1) from a more restrictive schedule to a less restrictiveschedule; or
(2) as a substance that is not a controlled substance;
if the board finds that the substance qualifies for reclassificationunder this chapter and that the same reclassification has been madein a controlled substance schedule under federal law.
(b) If the board reclassifies a controlled substance undersubsection (a), the board shall recommend the same reclassificationto the general assembly under section 1 of this chapter.
(c) Notwithstanding a provision in this chapter that classifies acontrolled substance in a more restrictive schedule than a ruleadopted under subsection (a), a person who manufactures,distributes, dispenses, possesses, or uses a controlled substance incompliance with the requirements applicable to the less restrictiveschedule to which a controlled substance is reclassified undersubsection (a) does not commit an offense under this article.
(d) Notwithstanding a provision in this chapter that classifies asubstance as a controlled substance, a person does not commit anoffense under this article if the board has reclassified the controlledsubstance as a substance that is not a controlled substance.
As added by P.L.200-1987, SEC.14.